- Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award…
SEATTLE, WA, Jan 6, 2025 - (ACN Newswire) - Spectral Capital Corporation (OTCQB: FCCN), a pioneer in Quantum as a Service (QaaS) computing and decentralized cloud infrastructure, is pleased to announce the achievement of a major patent milestone as the first step in its plan…
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](https://www.so-co-it.com/wp-content/themes/socoit20/timthumb.php?src=wp-content%2Fuploads%2F716035.jpg&q=90&w=460&h=260&zc=1%20width=460%20height=260)
Back to media releases (https://norgine.com/media) Next media release (https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/) Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, i…
As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe. The Warnow seems to be flowing…
ZEISS Group revenue increased to just under 11 billion euros (10.894 billion euros), (up 8% on the prior year) – EBIT 1,444 million euros (prior year: 1,686 million euros, EBIT margin 13%). Mixed development in the segments. High spend on research and development equivalent to…
- Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October 2024 by the Committee…
Infosys: Strong growth of 6.1% YoY in CC, 80 bps YoY operating margin expansion
- Large deal TCV of $2.5 billion including 63% net new; Headcount increased by 5,591…
Infosys and Tennis Australia Create New Generative AI Innovations at the Australian Open 2025
Launch of Beyond Tennis : A new generative AI tennis league with AI players…
BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System
The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market BAIBYS™ (https://www.baibys.com/),…
Nomination period for the Broermann Medical Innovation Award started
- Prize money of one million euros higher than the prize money for the…
TANAKA Group Company EEJA to Exhibit at 39th NEPCON JAPAN
Premiering new products in the field of plating technologies and processes to help meet rising…
ULVAC Launches New Deposition System for Semiconductor Applications: Model “ENTRON-EXX”
Supporting Enhanced Productivity and Accelerated Development Speed with Advanced Data Collection, Analysis Capabilities, and Expandability.…
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](https://www.so-co-it.com/wp-content/themes/socoit20/timthumb.php?src=wp-content%2Fuploads%2F716035.jpg&q=90&w=223&h=105&zc=1%20width=223%20height=105)
Recent Comments